Thomas Schwaab

MD, PhD
Urology
Buffalo Spree Top Doctor 2024

Dr. Schwaab is a Buffalo Spree Top Doctor! See all of our physicians who made this year's list.

Top Doctors 2024

Cancers Treated:

Specializing In:

Bladder cancer Kidney cancer Prostate cancer Testicular cancer Partial nephrectomy Robotic kidney surgery Retroperitoneal surgery IVC surgery advanced in kidney cancers

Research Interests:

Role for partial nephrectomy Immunotherapy for bladder, prostate and kidney cancers Robotic simulation

About Thomas Schwaab

Biography:

Thomas Schwaab, MD, PhD, is an Associate Professor of Oncology and Immunology, and joined the Institute’s faculty in 2009

Positions

Roswell Park Comprehensive Cancer Center
  • Associate Professor of Oncology
  • Department of Urology
  • Department of Immunology

Background

Education and Training:

  • MD - Medizinische Hochscule Hannover, Hannover, Germany

Residency:

  • Klinikum Lippe-Detmold, Detmold, Germany
  • Dartmouth-Hitchcock Medical Center, Lebanon, NH

Fellowship:

  • Tumor Immunotherapy Program, Dartmouth College, Hanover, NH

Board Certification:

  • Urology, American Board of Urology

Featured on Cancer Talk


Publications

Full Publications list on PubMed
  • Brewer K, O'Malley RL, Hayn M, Safwat MW, Kim H, Underwood W 3rd, Schwaab T. Perioperative and renal function outcomes of minimally invasive partial nephrectomy for t(1b) and t(2a) kidney tumors.Journal of endourology 2012; 263:244-248
  • O'Malley RL, Hayn MH, Hellenthal NJ, Kim HL, Underwood W 3rd, Schwaab T. Safety and outcomes of surgical treatment of renal cell carcinoma in the elderly. Canadian journal of urology 2012; 191:6111-6117
  • O'Malley RL, Brewer KA, Hayn MH, Kim HL, Underwood W 3rd, Pili R, Schwaab T. Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: are surgical complications or disease related factors responsible? . Urology 2011; 783:595-600
  • Hellenthal NJ, Mansour AM, Hayn MH, Schwaab T. Renal cell carcinoma in octogenarians: nephron sparing surgery should remain the standard of care. Journal of urology 2011; 1852:415-420
  • Hayn MH, Schwaab T, Underwood W, Kim HL. RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy. BJU international 2011; 1086:876-881
  • Schwaab T, Ernstoff MS. Therapeutic vaccines in renal cell carcinoma. Therapy 2011; 48:369-377
  • Schwaab T, Schwarzer A, Wolf B, Crocenzi TS, Seigne JD, Crosby NA, Cole BF, Fisher JL, Uhlenhake JC, Mellinger D, Foster C, Szczepiorkowski ZM, Webber SM, Schned AR, Harris RD, Barth Jr RJ, Heaney JA, Noelle RJ, Ernstoff MS. Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients. Clinical cancer research 2009; 1515:4986-4992
  • Schwaab M, Hansen S, Gurr A, Schwaab T, Minovi A, Sudhoff H, Dazert S. Protein isolation from ear wax made easy. European archives of oto-rhino-laryngology 2009; 26611:1699-1702